AMERICAN CENTURY COMPANIES INC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 748054
KANSAS CITY, MO
Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,084,826
+$354,700 QoQ
Shares Held
40,495
-1.0% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERICAN CENTURY COMPANIES INC holds $3,844,388,733 across 170 Biotechnology names. LGND ranks #47 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,802,363 | $596,347,845 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
562,097 | $434,298,626 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
813,285 | $363,164,283 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,397,119 | $319,563,028 | |
| 5 | INSM |
INSMED Inc
|
925,799 | $151,386,652 | |
| 6 | ARGX |
Argenx SE
|
173,700 | $126,844,425 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,663,803 | $124,934,967 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
4,138,416 | $102,467,180 |
All Filings in LGND
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,084,826 | 40,495 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,730,126 | 40,885 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,077,938 | 45,602 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,067,740 | 44,579 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,253,543 | 40,456 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,989,944 | 37,237 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,488,737 | 34,856 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,457,611 | 29,167 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $1,832,105 | 25,063 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,360,908 | 19,055 | Shares | Defined | 2024-02-13 | |
| 2023-06-30 | $4,792,559 | 66,471 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,917,044 | 66,844 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $4,549,013 | 68,099 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,316,857 | 43,130 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $153,785 | 1,596 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $128,108 | 1,474 | Shares | Defined | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||